Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 12, Pages 811-812Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd.2017.177
Keywords
-
Ask authors/readers for more resources
The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
